Polyendocrine Metabolic Ovarian Syndrome (PMOS): Why PCOS is Being Renamed

For years, millions of women have navigated a diagnosis that suggested their primary issue was the presence of ovarian cysts. However, a global effort to improve diagnosis and patient care has led to a significant shift. Polycystic Ovary Syndrome (PCOS) has been renamed Polyendocrine Metabolic Ovarian Syndrome (PMOS).

This isn’t just a semantic update. The name change reflects a deeper medical understanding of the condition as a complex, long-term endocrine disorder rather than a localized ovarian issue. By shifting the focus toward the metabolic and polyendocrine nature of the syndrome, healthcare providers can better address the systemic impacts on a patient’s health.

From PCOS to PMOS: What’s Changing?

The transition to Polyendocrine Metabolic Ovarian Syndrome (PMOS) aims to correct a long-standing misunderstanding. The term “polycystic” led many to believe the condition was defined by cysts on the ovaries. In reality, the condition is characterized by fluctuations in hormones that impact weight, mental health, skin, and the reproductive system.

More than 50 patient and professional organizations, including the Endocrine Society, collaborated to develop this new terminology. The goal is to ensure that the diverse features of the condition are recognized and that patients receive comprehensive care that extends beyond reproductive health.

The Danger of the “Cyst” Misconception

One of the primary drivers for this change is the clinical reality that the old name was misleading. Professor Helena Teede, an endocrinologist at Monash Health and Director of Monash University’s Monash Centre for Health Research & Implementation, led the name change process. Teede notes that there is actually no increase in abnormal cysts on the ovary, yet the previous name centered the entire diagnosis around them.

This focus on “cysts” often resulted in:

• Delayed Diagnoses: Patients who didn’t have visible cysts on an ultrasound were often told they didn’t have the condition, despite exhibiting all other symptoms.
• Inadequate Treatment: By viewing the condition as an ovarian issue, the metabolic and endocrine components—such as insulin resistance and hormonal imbalances—were sometimes overlooked.
• Limited Awareness: The complexity of the disorder was reduced to a misunderstanding about ovarian anatomy.

Understanding the Symptoms and Causes of PMOS

PMOS is a hormonal imbalance that occurs when the ovaries produce unusually high levels of androgens. This imbalance disrupts reproductive hormones, leading to a wide array of systemic symptoms. According to the Cleveland Clinic, common indicators include:

Reproductive and Physical Symptoms

• Irregular Menstrual Cycles: This includes missed periods and unpredictable ovulation.
• Dermatological Issues: Excess hair growth (hirsutism) and acne are common due to elevated androgen levels.
• Infertility: Imbalanced hormones can make it difficult to conceive.

Metabolic and Long-term Health Risks

Because PMOS is a metabolic disorder, it affects more than just the reproductive system. People living with PMOS face a higher risk for several serious health conditions, including:

• Type 2 Diabetes: Metabolic dysfunction often leads to insulin resistance.
• Hypertension: There is an increased risk of high blood pressure.
• Weight Management: Hormonal fluctuations frequently impact weight and metabolic rate.

A Global Health Priority

The scale of this condition is immense. PMOS affects approximately 1 in 8 women, impacting more than 170 million women worldwide. Given its prevalence, the move toward a more accurate name is a critical step in ensuring these women receive the long-term, multidisciplinary care they require.

Frequently Asked Questions

Do I need to change my diagnosis if I was already diagnosed with PCOS?

Medical records will naturally transition to the new terminology, but the underlying clinical management remains the same. The name change is intended to improve how doctors approach your care and how the medical community understands the syndrome.

Can I have PMOS without having cysts on my ovaries?

Yes. Despite the previous name, “polycystic” ovaries are not a requirement for diagnosis. Many people with PMOS do not have visible cysts on an ultrasound but still experience the hormonal and metabolic effects of the condition.

Who is responsible for this name change?

The process was led by Professor Helena Teede and supported by more than 50 professional and patient organizations, including the Endocrine Society.

Looking Forward

The renaming of PCOS to PMOS marks a turning point in women’s health. By removing the misleading focus on ovarian cysts, the medical community is paving the way for earlier detection and more holistic treatment plans. As awareness of the metabolic and endocrine nature of PMOS grows, patients can expect care that addresses not only their reproductive goals but their overall long-term wellness.